105 related articles for article (PubMed ID: 16427687)
1. Infection of human papillomavirus and overexpression of dihydrodiol dehydrogenase in uterine cervical cancer.
Ueda M; Hung YC; Chen JT; Chiou SH; Huang HH; Lin TY; Terai Y; Chow KC
Gynecol Oncol; 2006 Aug; 102(2):173-81. PubMed ID: 16427687
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients.
Chen YJ; Yuan CC; Chow KC; Wang PH; Lai CR; Yen MS; Wang LS
Gynecol Oncol; 2005 Apr; 97(1):110-7. PubMed ID: 15790446
[TBL] [Abstract][Full Text] [Related]
3. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
4. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.
Lai CH; Chang CJ; Huang HJ; Hsueh S; Chao A; Yang JE; Lin CT; Huang SL; Hong JH; Chou HH; Wu TI; Huang KG; Wang CC; Chang TC
J Clin Oncol; 2007 Aug; 25(24):3628-34. PubMed ID: 17704412
[TBL] [Abstract][Full Text] [Related]
5. Detection of HPV16 and 18 by in situ hybridization in precancerous and cancerous lesions of cervix.
Choudhury M; Singh S
Indian J Pathol Microbiol; 2006 Jul; 49(3):345-7. PubMed ID: 17001881
[TBL] [Abstract][Full Text] [Related]
6. Differences in human papillomavirus type may influence clinical outcome in early stage cervical cancer.
Dahlgren L; Erlandsson F; Lindquist D; Silfverswärd C; Hellström AC; Dalianis T
Anticancer Res; 2006; 26(2A):829-32. PubMed ID: 16619476
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.
Hsu NY; Ho HC; Chow KC; Lin TY; Shih CS; Wang LS; Tsai CM
Cancer Res; 2001 Mar; 61(6):2727-31. PubMed ID: 11289154
[TBL] [Abstract][Full Text] [Related]
8. HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India.
Berlin Grace VM
Indian J Cancer; 2009; 46(3):203-7. PubMed ID: 19574671
[TBL] [Abstract][Full Text] [Related]
9. [Significance of pelvic lymph node human papillomavirus DNA detection in cervical cancer].
Liu GB; Liu X; Pang ZJ; Xing FQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1236-9. PubMed ID: 16234097
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type distribution in cervical cancer in Delhi, India.
Bhatla N; Dar L; Patro AR; Kriplani A; Gulati A; Verma K; Broor S; Shah KV; Gravitt PE
Int J Gynecol Pathol; 2006 Oct; 25(4):398-402. PubMed ID: 16990719
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG
Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus and mutated H-ras oncogene in cervical carcinomas and pathological negative pelvic lymph nodes: a retrospective follow-up.
Landro ME; Dalbert D; Picconi MA; Cúneo N; González J; Vornetti S; Bazán G; Mural J; Basiletti J; Teyssié AR; Alonio LV
J Med Virol; 2008 Apr; 80(4):694-701. PubMed ID: 18297710
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of expression of nuclear factor kappaB, inhibitor protein kappaB, and Bcl-2 in cervical cancer to human papillomavirus infection].
Xia KD; Chen XM; Lin QA; Dong HY; Chen S; Zhang LF
Ai Zheng; 2005 Nov; 24(11):1350-3. PubMed ID: 16552961
[TBL] [Abstract][Full Text] [Related]
14. Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis.
Weinberger PM; Yu Z; Kountourakis P; Sasaki C; Haffty BG; Kowalski D; Merkley MA; Rimm DL; Camp RL; Psyrri A
Otolaryngol Head Neck Surg; 2009 Sep; 141(3):382-9. PubMed ID: 19716018
[TBL] [Abstract][Full Text] [Related]
15. The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis.
Wang W; Wang S; Song X; Sima N; Xu X; Luo A; Chen G; Deng D; Xu Q; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Jun; 105(3):571-7. PubMed ID: 17433827
[TBL] [Abstract][Full Text] [Related]
16. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
Zheng Y; Peng ZL; Lou JY; Wang H
Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus prevalence in invasive cervical carcinomas in Bulgaria.
Todorova I; Ganchev G; Shikova E
J Clin Pathol; 2010 Dec; 63(12):1121-3. PubMed ID: 20943820
[TBL] [Abstract][Full Text] [Related]
18. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
19. HPV+ cervical carcinomas and cell lines display altered expression of caspases.
Aréchaga-Ocampo E; Pereira-Suárez AL; del Moral-Hernández O; Cedillo-Barrón L; Rodríguez-Sastre MA; Castillo-Alvarez A; López-Bayghen E; Villegas-Sepúlveda N
Gynecol Oncol; 2008 Jan; 108(1):10-8. PubMed ID: 17936882
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the presence of high risk human papillomavirus in retinoblastoma tissue from nonfamilial retinoblastoma in developing countries.
Shetty OA; Naresh KN; Banavali SD; Shet T; Joshi R; Qureshi S; Mulherkar R; Borges A; Desai SB
Pediatr Blood Cancer; 2012 Feb; 58(2):185-90. PubMed ID: 22021092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
